January 2013

Marianne Berwick, Ph.D., M.P.H.Internal Medicine, MSC10 5550, 1 University of New Mexico, Albuquerque, NM 87131-0001

Home Address: 305 Hermosa Drive, SE, Albuquerque, NM 87108

 Educational History:

PhD. 1987, Yale University, New Haven, CT, Environmental Epidemiology

M.P.H. 1979, Yale University School of Medicine, New Haven, CT, Environmental Health Studies

B.A. 1963, University of California, Los Angeles, CA, English

 Employment History:

Professor, January 2004 – present. University of New Mexico School of Medicine, Department of Internal Medicine. Albuquerque, NM.

Member – Attending Epidemiologist, September 2003 – December 2003. Memorial Sloan-Kettering Cancer Center, Department of Epidemiology and Biostatistics, New York, NY

Associate Member – Associate Attending Epidemiologist, September 1997 – August 2003. Memorial Sloan-Kettering Cancer Center, Department of Epidemiology and Biostatistics, New York. NY

Assistant Member – Assistant Attending Epidemiologist, September 1994 – August 1997. Memorial Sloan-Kettering Cancer Center, Department of Epidemiology and Biostatistics, New York, NY

Director of Epidemiology – January 1993 – August 1994. Cancer Prevention Research Institute, New York, NY

Senior Epidemiologist – September 1991 – December 1992. Cancer Prevention Research Institute, New York, NY

Lecturer – September 1988 – August 1991. Yale University Department of Epidemiology and Public Health, New Haven, CT

Associate Research Scientist – September 1986 – August 1988. Yale University, Department of Epidemiology and Public Health, New Haven, CT

Teaching Assistant – February 1986 – August 1986. Yale University, Department of Epidemiology and Public Health, New Haven, CT.

1

Acting Instructor – September 1985 – January 1986. Yale University, Department of Epidemiology and Public Health, New Haven, CT

Graduate Assistant in Research - September 1984 – January 1986. J.B. Pierce Foundation, New Haven, CT

Visiting Scientist – June 1978-August 1978 – Virus Research Laboratory, University of Ibadan, Ibadan, Nigeria

Human Ecologist – June 1977 – August 1977. The Nature Conservancy, Middletown, CT

Research Associate – February 1970 – August 1971. The Smithsonian Institution, Bombay Natural History Society, Yale University, World Wildlife Fund. The Gir Forest, Gujarat, India

 Employment History Concurrent:

Head, Molecular Epidemiology Laboratory – September 1994 – December 2003. Memorial Sloan-Kettering Cancer Center, Department of Epidemiology and Biostatistics, New York, NY

Associate Professor of Epidemiology – September 2001 – December 2003. Cornell University Medical School, Department of Public Health, New York, NY

Assistant Professor of Epidemiology – September 1994 – August 2001. Cornell University Medical School, Department of Public Health, New York, NY

Adjunct Member – September 2001 – present – Rockefeller University, New York, NY

Research Affiliate – September 1993 – present – Yale University, Department of Epidemiology and Public Health, New Haven, CT

Research Assistant Professor – September 1991 – December 1997. Institute of Environmental Medicine, New York University, New York, NY

 Professional Recognition, Honors:

The Wilbur Downs International Travel Award. Yale University, School of Medicine, 1978.

Hull Award, Yale University School of Medicine, 1988. Melanoma Research Foundation Award, 1988. LILAC Award for Cancer Research, 1996. Byrne Fund Award, 1997-1999. David Klein Foundation Award, 2001. Peter Fink Memorial Lectureship, 2003. Stanley Davidson Lecture (endowed), 2006 Established Researcher Award 2006 of the Society of Melanoma

Research Senior Research Award 2007 – Department of Internal Medicine, UNM

2

NCI Subcommittee A Member (2008-2012) Scientific Counselor, National Academy of Science – Radiation Effects

Research Foundation (2005-2015) Australian Society for Oncology Award – Marryalyan Award, 2008 UNM Excellence in Population Science Research 2010. Distinguished Professor - 2012

 Memberships in Professional Societies

Society for Melanoma Research (Founding member, Secretary/Treasurer 2003-2009)

American Association for Cancer Research/Molecular Epidemiology Group

Society for Epidemiologic Research American College of Epidemiology, Fellow American Society for Preventive Oncology American Society for Photobiology Society for Investigative Dermatology

 Other extramural professional activities

Ad hoc reviewer: o American Journal of Epidemiologyo American Journal of Human Geneticso Annals of Behavioral Medicineo Annals of Internal Medicineo Archives of Dermatologyo Archives of Internal Medicineo British Journal of Dermatologyo British Medical Journalo Cancero Cancer Causes and Controlo Cancer Epidemiology, Biomarkers and Preventiono Cancer Researcho Clinical Cancer Researcho Community Epidemiology and Healtho Epidemiologyo European Journal of Epidemiology and Cancer Preventiono Health Psychologyo International Journal of Cancero International Journal of Epidemiologyo Journal of the American Medical Associationo Journal of Clinical Oncologyo Journal of Investigative Dermatologyo Journal of the National Cancer Instituteo The Lancet

3

o Melanoma Researcho Mutagenesiso Nature Geneticso New England Journal of Medicineo Photobiology and Photochemistryo Preventive Medicineo Psychology and Healtho Science

Editorial Board Member

o Pigment Cell and Melanoma Research – 2007-2009o Cancer Epidemiology, Biomarkers and Prevention - currento Cancer - currento DermClips – American Academy of Dermatology CME

publication - current

External Advisory Board Member

o MDAnderson Melanoma SPORE – November 2005 to 2009o Wistar Skin SPORE – December 2005 to 2009o NYU SPORE application – June 2008 to 2009o Fred Hutchinson Cancer Research Center and New Mexico

State University U54 – August 2008 – to presento University of Illinois at Chicago – R25 Cancer Education –

post-doctoral training program – 2010 – 2014o Genetics and Epidemiology Research Institute – November

2012 to present, University of California, Irvine

Grant Reviews

o NCI Scientific Review Group Member – Subcommittee A – 2008 to 2013

o Italian Grant Review, Genoa, Italy. 2012o Austrian Grant Review, 2012.o Special Emphasis Panel for EPIC (members in conflict) –

November 2009; February 2010o NIH – Innovator Awards - 2011o Australia Fellowship, ad hoc reviewer, 2010o State of Texas Population Science Reviews, April 2010o GlaxoSmithKline International Ethnic Research Committee –

November 2009o NCI Scientific Review Group Member (SRG) E, Cancer

Epidemiology, Prevention and Control – September 2003 – 2008

4

o NCI CCSG Review of St. Jude Cancer Center (ad hoc) - 2007

o UK special grant reviews – 2006, 2007, 2008o NIEHS ad hoc member – 2005-2006o NIEHS Program Project Review – USC - 2005o NCI Review: Intramural Program Genetic Epidemiology –

May 2004.o NIH NCMHD Special Emphasis Panel - 2002o NCI Program Projects, Ad hoc Reviewer, 1999, 2001-2003o Ad hoc Reviewer – NCI EDC2 – 1998, 2000, 2001o NCI SPORE Review – Skin Cancer - 2001o Ad hoc Reviewer - Australian NHMRC Grants – 2003o Department of Defense – Grant Reviews – 1993 - 2003o American Cancer Society, Ad Hoc Reviewer, Molecular

Epidemiology - 2002o Grant Review – Cancer Society of New Zealand – 2001o Canadian Institute of Cancer Grant Reviews – 2001o Grant Review - Italian Minister of University Research on

Science and Technology 1999- 2007o Canadian National Health System Cancer Grant Review –

1999o NCI - Safety and Protocol Review - 1993

Administrative work with professional societies

o Organizer, 4th International Melanoma Congress, New York 2007

o Program Committee, AACR, 2005, 2006, 2007o WHO Melanoma Congress, Vancouver 2005, Program

Committeeo Secretary-Treasurer, Society for Melanoma Research,

2003-2010o Steering Committee, Melanoma Research Foundation,

2004- 2011o Steering Committee, Society for Melanoma Research,

2003-presento Head, Membership Committee, AACR/MEG, 2004-2006o Admissions Committee, American College of Epidemiology,

2003-2004o Scientific Program Committee, 6th World Conference on

Malignant Melanoma, 2005o Scientific Program Committee, IDEA-EDEN, Venice 2004o Scientific and Educational Committee, AACR/MEG, 2002o Chair, Nominating Committee, AACR/MEG, 2002

5

o Scientific Program Committee, European Dermato-epidemiology Group, 2000

o Chairman, Scientific Program Committee, International Dermato-epidemiology Association 2000-2001

o Basic Science Committee and Sarcoma Committees of the American College of Surgeons, 1999-2003

o Epidemiology Advisory Group for AmDEC, New York City, NY, 2003

o Editorial Board, Melanoma Update, Memorial Sloan-Kettering Cancer Center, 1994-2003.

o Board on Gender Disparities, WICR, AACR, 2012.

Invited lectures: 1990. Ozone Depletion and Melanoma. Launceston Hospital Association,

Tasmania, Australia 1991. Variability in Measurement of DNA Repair Capacity. Columbia

University Seminar Series, New York, NY 1992. Case Control Study of Skin Self-examination and Melanoma.

Columbia University Seminar Series, New York, NY. 1992. Screening and Melanoma. Canadian Symposium of Ultra-violet

radiation and Diseases, Ottawa, Ontario 1992. Risk Factors for Melanoma. Connecticut Chapter - American

Cancer Society, Wallingford, CT. 1992. Preventing Melanoma. Nursing Rounds, St. Vincent’s Hospital,

Bridgeport, CT. 1993. The Contribution of Early Detection to the Rising Incidence of

Melanoma. Memorial Sloan Kettering Epidemiology Series. 1994. Risk Factors for Melanoma. Bristol Hospital Grand Rounds, Bristol,

CT. 1995. The Latest in Prevention of Skin Cancer . Memorial Sloan-

Kettering Cancer Center, Docents Lecture, New York 1995. Can Skin Self-Examination Prevent Melanoma? Yale University

Chronic Disease Epidemiology Lecture Series, New Haven, Connecticut. 1995. Preventing Melanoma: Combining Epidemiology and Laboratory

Tools. Harvard University - Cancer Prevention Seminars, Boston, MA 1996. Preventing Melanoma: The Role of the Nurse. Nursing Grand

Rounds, Memorial Sloan-Kettering Cancer Center. New York. 1996. Predicting Risk for Melanoma. Tasmanian Hematology,

Immunology, and Neoplasia Group. Tasmania, Australia. 1996. p16 and DNA Repair in Melanoma. Tasmanian Hematology,

Immunology, and Neoplasia Group. Tasmania, Australia. 1996. Melanoma Risk Algorithm. Menzies Centre for Population Health

Research, University of Tasmania, Hobart, Tasmania, Australia. 1996. Epidemiology and Prevention of Melanoma. LILAC (Long Island

League Against Cancer) Long Island, New York.

6

1996. Screening for Cutaneous Melanoma: An Update. Third Symposium on the Epidemiology of Melanoma and Non-Melanocytic Skin Cancer. Vancouver, British Columbia.

1996. Screening for Melanoma by Skin Self-Examination. University of Pennsylvania. Philadelphia, PA.

1996. Preventing Melanoma. The Society of Memorial Sloan-Kettering Cancer Center. New York, NY

1996. What is the Cause of Melanoma? Leeds Oncology Update. Imperial Cancer Research Fund, University of Leeds, UK.

1996. Vitamin E and Cancer Chemoprevention. Nutrition Group, Memorial Sloan-Kettering Cancer

1996. The Epidemiology of Melanoma. Baruch College, New York City. 1997. Melanoma Prevention. Current and Future. Surgery Research

Seminar, Memorial Sloan-Kettering Cancer Center, New York, NY 1997. Estimating Individual Risk for Melanoma. The Society of Memorial

Sloan-Kettering Cancer Center, New York, NY 1997. Summer Smart: Skin Cancer Prevention and Early Detection.

“What’s a Body to Do?” Memorial Sloan-Kettering Cancer Center, New York, NY.

1998. Sunscreens and Melanoma: The Epidemiologic Perspective. Yale University Chronic Diseases and Epidemiology Seminar, New Haven, CT

1998. Cancer Epidemiology: Two Current Problems - Childhood Cancer Increases and Sunscreens, Brookhaven National Laboratory, Upton, New York.

1998. Prevention of Melanoma: The Role of Genetics, Mt. Sinai School of Medicine, New York, NY.

1998. Prevention of Melanoma: The Role of Genetics. Arizona Cancer Center, Tucson, AZ.

1999. Preliminary Results: Randomized Trial of Alpha-Tocopherol. Surgery Research Seminar, Memorial Sloan-Kettering Cancer Center, New York, NY.

1999. Can Melanoma Be Prevented? Medicine Grand Rounds, Memorial Sloan-Kettering Cancer Center, New York, NY.

1999. The Epidemiology of Melanoma in Those Over 65, Institute of Medicine, National Academy of Science, Washington, DC.

2000. Can Melanoma Be Prevented? New South Wales Cancer Council. Sydney, Australia.

2000. Can Melanoma Be Prevented? Cornell University Department of Public Health Seminar Series, New York, NY.

2001. Can Melanoma Be Prevented? Mt. Sinai Cancer Center, New York, NY

2001. Genetic Susceptibility to Melanoma, The Roffo Institute, Buenos Aires, Argentina.

2001. Integration of Measures of DNA Repair in Epidemiologic Studies, German Cancer Research Center, Division of Toxicology and Cancer Risk Factors, Heidelberg, Germany

7

2001. Melanoma: A Model for Gene-Environment Interaction. Yale University School of Medicine, Department of Epidemiology and Public Health, Departmental Seminar. New Haven, CT.

2001. Melanoma: A Paradigm for Gene-Environment Interaction. City College of New York, Department of Biology, New York, NY.

2002. Melanoma: Genetics or Environment. The Peter Fink Memorial Lecture, Memorial Sloan-Kettering Cancer Center, New York, NY,

2003. Fanconi Anemia Among Heterozygotes. Grand Rounds Department of Community Medicine, Mount Sinai School of Medicine, New York, NY.

2003. The Epidemiology of Bladder Cancer, Urology Grand Rounds, Memorial Sloan-Kettering Cancer Center, New York, NY

2003. DNA Repair – Can Epidemiology Tell Us Anything? New York University, New York, NY.

2003. New Directions in the Development of Melanoma, Cancer Smart Lecture, Memorial Sloan-Kettering Cancer Center, New York, NY

2003. New Clues to the Etiology of Melanoma from Epidemiology, Surgery Grand Rounds, Memorial Sloan-Kettering Cancer Center, New York, NY

2003. Selection of Controls – A Novel Approach, MEG/AACR Workshop for Junior Investigators, Washington, DC

2003. Can Sunscreens Prevent Melanoma? - Cancer Prevention and Control NCI Awardees – Keynote Speech – Denver, CO

2004. Genetic Factors involved in Survival with Soft Tissue Sarcoma. Pharmacology Seminar, University of New Mexico, Albuquerque, NM.

2004. DNA Repair. Can Epidemiology Tell Us Anything? MPH Seminar Series, University of New Mexico, Albuquerque, NM.

2004. Meet the Expert – Melanoma Session. American Society for Clinical Oncology, New Orleans, LA,

2004. Progress in the Understanding the Etiology of DNA Repair in Cancer. The Cancer Prevention and Control Colloquia Lecture Series, NCI Office of Preventive Oncology, Bethesda, MD.

2004. The Contribution of Molecular Epidemiology to Understanding Cancer: Melanoma as a Model. Joint Rounds: Department of Internal Medicine and Pathology. Albuquerque, NM.

2005. How Could Sun Exposure Prevent Melanoma? Moffitt Cancer Center, Tampa, FL.

2005. How Could Sun Exposure Prevent Melanoma? University of Toronto, Toronto, CANADA

2005. How Could Sun Exposure Prevent Melanoma? UNM CRTC Special Lecture, Albuquerque, NM.

2005. Ultraviolet Radiation in the Pathogenesis of Melanoma. Perspectives in Melanoma IX. Tampa, FL

2005. How Could Sun Exposure Prevent Melanoma? Department of Family and Community Health MPH Seminar, Albuquerque, NM

2005. How Could Sun Exposure Prevent Melanoma? MDAnderson Cancer Center, Houston, TX

8

2006. The Role of the Epidemiologist in Cancer Prevention. Pathology Grand Rounds, Albuquerque, NM

2006. How COULD the Sun Be Helpful in Skin Cancer? AACR Meeting, Washington, DC

2006. Melanoma Epidemiology: Where are we headed? Sun, Sex, and Skin Cancer, Royal College of Physicians of Edinburgh, Edinburgh, Scotland.

2006. Prevalence, Penetrance and Mutation Characteristics of CDKN2A in GEM. Melanoma Day, University of Sydney, June 15, 2006.

2006. GEM: Genes, Environment and Melanoma. An International Study of Melanoma. Dublin, Ireland, July 31, 2006.

2006. Could the SUN Prevent Melanoma Progression? Arizona Cancer Center, Tucson, Arizona. September 19, 2006.

2006. Gene-environment interaction and melanoma etiology. University of California, Irvine, Chao Cancer Center, December 5, 2006.

Western IDeA States’ Symposium, A Darwinian Perspective on Cancer, March 15-17, 2007, Albuquerque

2007. Invited Speaker: Symposium: Solar Radiation and Human Health, Committee for Geomedicine, The Norwegian Academy of Science and Letters, Oslo, Norway – May 10-11.

2007. Invited Speaker: International Studies of Melanoma, World Congress of Dermatology, Buenos Aires, Argentina – October 3-5.

2007. Invited Speaker. UV-Radiation and Health. Karolinska Institute, Stockholm, Sweden. – October 18

2007. Invited Speaker. 3rd International Congress on Melanoma. Epidemiology Session. New York, NY – November 2

2008. Keynote Speaker. Melanoma Conference, University of North Carolina, Chapel Hill, NC – February 28.

2008. Keynote Speaker. Australian Society for Clinical Oncology, Sydney, Australia – November 16, 2008.

2008. Pigmentation and the Molecular Epidemiology of Melanoma. 4th International Congress on Melanoma. Sapporo, Japan

2008. Methylation and Melanoma. 4th International Congress on Melanoma. Sapporo, Japan

2009. Cancer Prevention – Sandia National Laboratories, Albuquerque, NM – April 15, 2009

2009. Melanoma and Sun Protection - World Congress of Epidemiology, May 12-16, 2009; Vienna, Austria.

2009. The Role of Vitamin D in Melanoma Progression - World Congress of Epidemiology, May 12-16, 2009; Vienna, Austria.

2009. Sunscreens and Melanoma, Revisited - World Congress of Epidemiology, May 12-16, 2009; Vienna, Austria.

2009. Vitamin D and Melanoma Progression. Invited Speaker. Society for Melanoma Research, Boston, November 2009.

2010. How Could Sun Exposure Prevent Mortality from Melanoma? Ohio State University Cancer Center, Grand Rounds, January 22, 2010.

2010. Vitamin D and Melanoma Progression. University of Arizona, Tucson, AZ, April 14, 2010.

9

2010. UV Exposure Patterns and Molecular and Clinical Phenotypes in an International Melanoma Study. AACR Annual Meeting, Washington, DC, April 20, 2010.

2010. Melanoma and Vitamin D – Where is the Balance? Epidemiology Seminar Series, University of North Carolina, April 23, 2010.

2010. Melanoma: How Can the Sun Improve Survival? Pathology Grand Rounds, University of New Mexico, May 13, 2010.

2010. Sun Exposure and Vitamin D: Benefits and Risks for Skin Cancer. 9th Congress of the Baltic Association of Dermatovenerologists. Tartu, Estonia, June 10, 2010.

2010. Melanoma Epidemiology: What’s New Under the Sun. 9 th Congress of the Baltic Association of Dermatovenereologists, Tartu, Estonia, June 11, 2010.

2011. MSKCC Melanoma Disease Management Team. Melanoma Update: What’s new under the sun? New York, NY January 21, 2011.

2011. College of Pharmacy: Melanoma – what’s new under the sun. University of New Mexico Pharmacy Lecture Series, Albuquerque, NM, January 24, 2011.

2011. ASPO, March 5, 2011, Las Vegas, NV. Solar Exposure and Melanoma: A Two-Edged Sword.

2012. Health Disparities Symposium – Chaminade University. Vitamin D: What Do We Know? Honolulu, HI, February 10, 2012.

2012. UV-Radiation induced disease – Roles of UVA and UVB. Survival in Melanoma – Seven-year Follow-up in GEM. May 24-26, 2012, Stockholm, Sweden.

2012. Melanoma Survival and UV Radiation. GenoMEL Meeting. June 18, 2012, Leiden, Holland.

2012. Shining a Light on Melanoma. Society for Integrative Oncology. October 9, 2012, Albuquerque, NM.

Meeting sessions chaired:

2012. Human Studies of UV-Induced Disease. UV-Radiation induced disease – Roles of UVA and UVB, Stockholm, Sweden, May 24-26, 2012.

2011. Prevention Session: International Society for Melanoma Research, November 11, 2011.

2010. Oncology Session. 9th Congress of the Baltic Association of Dermatovenerologists. Tartu, Estonia, June 10, 2010.

2009. Epidemiology Session: World Congress of Epidemiology, May 12-16, 2009; Vienna Austria.

2009. Education Session: Measurement of Health Disparities, February 3, 2009. AACR Conference on Health Disparities, Phoenix, Az.

2007. Studies of Human Health, UV-Radiation and Health – October 17-18, Karolinska Institute, Stockholm, Sweden

2007. Epidemiology Session. World Congress of Dermatology, Buenos Aires, Argentina, October 5.

10

2007. Spotlight Session: Melanoma Risk, Society for Epidemiologic Research, June 2007, Boston, MA

2006. Prevention of Melanoma. AACR Cancer Prevention, Boston, MA 2006. Epidemiology of Melanoma. Keystone Conference, Santa Fe, NM 2005. Ultraviolet Radiation and Melanoma. Perspectives in Melanoma IX.

Tampa, FL, November 17, 2005. 2005, 6th World Congress of Melanoma, Epidemiology, Vancouver, BC,

CA. September 6, 2005. 2005, Educational Forum: Molecular Epidemiology, International

Environmental Mutagen Society, San Francisco, CA, September 3, 2005 2005, AACR, Functional DNA Repair and Epidemiology, Anaheim, CA,

April 16-20, 2005. 2004, Society for Melanoma Research, Molecular Epidemiology 2004, Enivronmental Mutagenesis Society, Human Variation and Cancer

Susceptibility 2003, AACR, Forum on Sunscreens 2002. Society for Investigative Dermatology, Epidemiology Symposium. 2002. American Society for Photobiology, Epidemiology Session. 2001. Congress of Epidemiology (Society for Epidemiology, Canadian

Society for Epidemiology), Symposium on Melanoma. 1996. CDC and American Academy of Dermatology Skin Cancer

Prevention I. Agenda Setting.

Scholarly Achievements

Original research or scholarly articles in refereed journals:

1. Berwick M. Nitrate levels in groundwater from the Fleuve, Senegal. Progress in Water Technology 1978; 11, 978;(1/2):117-120.

2. Leaderer BP, Zagraniski RT, Berwick M, Stolwijk JAJ. Assessment of exposure to indoor air contaminants from combustion sources: methodology and application. American Journal of Epidemiology 1986;124:275-289.

3. Leaderer BP, Zagraniski RT, Berwick M, Stolwijk JAJ. Predicting NO2 levels in residences based upon sources and source use: a multivariate model. Atmospheric Environment 1987;21(2):361-368.

4. Berwick M, Leaderer BP, Zagraniski RT, Stolwijk JAJ. Lower respiratory symptoms in children exposed to nitrogen dioxide from unvented combustion sources. Environment International 1989;15:369-373.

5. Berwick M, Thompson WD, Roush G. Evaluating the efficacy of skin self-exam and other surveillance measures in persons at various levels of risk for cutaneous malignant melanoma: an ongoing case-control study. Advances in Cancer Control: Innovations and Research 1989:297-306.

11

6. Bolognia JL, Berwick M, Fine J. Complete follow-up and evaluation of a skin cancer screening in Connecticut. Journal of the American Academy of Dermatology 1990;23:1098-1105.

7. Barnhill R, Barnhill MA, Berwick M, Mihm M. The histological spectrum of pigmented spindle cell nevus: a review of 120 cases with emphasis on atypical variants. Human Pathology 1990;22:52-58.

8. Berwick M, Bolognia JL, Heer C, Fine J. The role of the nurse in skin cancer screening and early detection. Seminars in Nursing Oncology 1 (February), 1991:64-71.

9. Bolognia J, Berwick M, Fine JA, Simpson P, Jasmin J. Sun protection in newborns: a comparison of educational methods. American Journal of Diseases of Children 1991;145:1125-1129.

10.Berwick M, Fine J, Bolognia JL. Sun exposure and sunscreen use following a community skin cancer screening day. Preventive Medicine 1992;21(3):302-310.

11.Bolognia JL, Headley A, Fine J, Berwick M. The histologic evaluation of pigmented lesions in Connecticut and its influence on the reporting of melanoma. Journal of the American Academy of Dermatology 1992;26:198-202.

12.Leffell D, Chen Y-t, Berwick M, Bolognia JL. Interobserver agreement in a community skin cancer screening setting. Journal of the American Academy of Dermatology 1993, 28(6):1003-1005.

13.Bruijn JA, Berwick M, Mihm M, Barnhill RL. Common acquired melanocytic nevi, dysplastic melanocytic nevi and malignant melanomas: an image analysis cytometric study. Journal of Cutaneous Pathology, 1993, 20(2):121-125.

14.Duncan LM, Berwick M, Bruijn JA, Byers HR, Mihm MC and Barnhill RL. Histopathologic recognition and grading of dysplastic melanocytic nevi: an inter-observer agreement study. Journal of Investigative Dermatology 1993, 100(3):3185-3215.

15.Leffell D, Berwick M, Bolognia JL. The effect of pre-education on patient compliance with full body examination in a public skin cancer screening. Journal of Dermatologic Surgery and Oncology, 1993, 19(7):660-663.

16.Barnhill RL, Busam KJ, Berwick M, Blessing K, Cochran AJ, Elder DE, Fandrey K, Karaoli T, White WL. Tumour vascularity is not a prognostic factor for cutaneous melanoma. Lancet 1994; 344:1237-8.

12

17.Burt RD, Vaughan TL, Nisperos B, Swanson M, Berwick M. A protective association between the HLA-A2 antigen and nasopharyngeal carcinoma in U.S. whites. International Journal of Cancer 1994, 56:465-467.

18.Chen Y-t, Zheng Tongzhang T, Holford TR, Berwick M, Dubrow R. Malignant melanoma incidence in Connecticut (United States): time trends and age-period-cohort modeling by anatomic site. Cancer Causes and Control 1994;5:341-350.

19.Berwick M, Dubin N, Luo S-t, Flannery J. No improvement in survival from melanoma diagnosed from 1973-1984. International Journal of Epidemiology 1994; 673-681.

20.Berwick M, Chen Y-t. Reliability of reported sunburn history in a case-control study of cutaneous malignant melanoma. American Journal of Epidemiology, 1995: 141:1033-7.

21.Travers RL, Sober AJ, Berwick M, Mihm MC, Barnhill RL, Duncan LM. Increased thickness of pregnancy-associated melanoma. British Journal of Dermatology 1995;132:876-883.

22.Busam KJ, Berwick M, Blessing K, Fandrey K, Kang S, Karaoli T, Fine J, Cochran AJ, White WL, Rivers J, Elder DE, Wen D-RP, Heyman BH, Barnhill RL. Tumour vascularity is not a prognostic factor for malignant melanoma of the skin. American Journal of Pathology 1995;147:1049-1056.

23.Vaughan TL, Shapiro JA, Burt RD, Swanson GM, Berwick M, Lynch CF, Lyon JL. Nasopharyngeal cancer in a low-risk population: Defining risk factors by histologic type. Cancer Epidemiology Biomarkers and Prevention 1996;5:587-594.

24.Barnhill RL, Fine JA, Roush GC, Berwick M. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study. Cancer 1996, 78;3:427-432.

25.Burt RD, Vaughan TL, McKnight B, Davis S, Beckmann, A-M, Smith AG, Nisperos B, Swanson GM, Berwick M. Associations between human leukocyte antigen type and nasopharyngeal carcinoma in Caucasians in the United States. Cancer Epidemiology, Biomarkers and Prevention 1996, 5;879-887.

26.Berwick M, Begg C, Fine JA, Roush GC, Barnhill RL. Screening for malignant melanoma by skin self-examination. Journal of the National Cancer Institute 1996:88:17-23.

27.Hu JJ, Roush GC, Berwick M, Dubin N, Mahabir S, Chandiramani M, Boorstein B. Effects of dietary supplementation of alpha-tocopherol on plasma glutathione and DNA repair activities. Cancer Epidemiology Biomarkers and Prevention 1996;5:263-270.

13

28.Chen Y-T, Dubrow RT, Zhengdong T, Barnhill RL, Berwick M. Malignant melanoma risk factors by anatomic site: a case-control study and polychotomous logistic regression analysis. International Journal of Cancer 1996;67:1-8.

29.Begg C, Huang Y, Berwick M. Separate estimation of primary and secondary cancer preventive impact: Analysis of a case-control study of skin self-examination and melanoma. Journal of the American Statistical Association 1996;91 (436):1381-1387.

30.Begg C, Berwick M. A note on the estimation of relative risks of rare genetic susceptibility markers. Cancer Epidemiology Biomarkers and Prevention 1997;6:99-103.

31.Hu JJ, Dubin N, Berwick M, Miesner J, Roses D, Harris M, Roush GC. Poly (ADP-Ribose) Polymerase in human breast cancer: A case-control analysis. Pharmacogenetics 1997;7(4).

32.Berwick M, Halpern A. Etiology and Epidemiology of Melanoma: Current Opinion in Oncology 1997;9:178-182.

33.Berwick M, Schantz S. Chemoprevention of Upper Aerodigestive Cancer. Cancer and Metastasis Review. 1997; 16:329-347.

34.Begg C, Satagopan J, Berwick M. A new strategy for evaluation the impact of epidemiologic risk factors for cancer with application to melanoma. Journal of the American Statistical Association 1998; 93(422):415-426.

35.Chen Y-t, Dubrow R, Zheng T, Barnhill RL, Fine JA, Berwick M. Sunlamp use and risk of cutaneous malignant melanoma: a population-based case-control study in Connecticut, USA. International Journal of Epidemiology 1998;27:758-765.

36.Smith M, Fine JA, Barnhill RL, Berwick M. Hormonal and reproductive influences and risk of melanoma in women. International Journal of Epidemiology 1998;27:751-757.

37.Margolis DJ, Rebbeck T, Halpern A, Fine JA, Barnhill RL, Berwick M. Validation of a melanoma model. Archives of Dermatology, 1998;134:1597-1601.

38.Farrow DC, Vaughan TL, Berwick M, Lynch CF, Swanson GM, Lyon JL. Diet and nasopharyngeal cancer in a low-risk population. International Journal of Cancer, 1998;78:675-679.

39.Weinstock MA, Martin RA, Risica PM, Berwick M, Lasater T, Rakowski W, Goldstein MG, Dube CE. Thorough skin examination for the early detection of melanoma. Preventive Medicine 1999; 17(3):169-75. PMID: 10987631

14

40.Nazar-Stewart V, Vaughan TL, Burt RD, Chen C, Berwick M, Swanson GM. Glutathione S-transferase M1 and susceptibility to nasopharyngeal carcinoma. Cancer Epidemiology, Biomarkers and Prevention, 1999;6:489-580.

41.Oliveria SA, Christos PJ, Halpern AC, Fine J, Barnhill RL, Berwick M. Patient knowledge, awareness and delay in seeking medical attention for malignant melanoma. Journal of Clinical Epidemiology 1999;52(11):1111-6.

42.Oliveria SA, Christos PJ, Halpern AC, Fine J, Barnhill RL, Berwick M. Evaluation of factors associated with skin self-examination. Cancer Epidemiology, Biomarkers and Prevention 1999;8:971-8.

43.Hu JJ, Chi CX, Frenkel K, Smith BN, Henfelt JJ, Roush GC, Mahabir S, Berwick M. Dietary supplementation of alpha-tocopherol decreases titers of antibody against 5-hydroxymethyl-2'-deoxyuridine (HmdU). Cancer Epidemiology, Biomarkers and Prevention 1999;8:693-8.

44.Busam KJ, Tan LK, Granter SR, Kohler S, Junkins-Hopkins J, Berwick M, Rosen PP. Epidermal growth factor, estrogen and progesterone receptor expression in primary sweat gland carcinomas and primary and metastatic mammary carcinomas. Modern Pathology 1999;12(8):786-93.

45.Berwick M, Headley A, Fine J, Bolognia JL. Skin self-examination in patients at risk for the development of melanoma: I. Nurse education. Journal of Cancer Education 2000;15:39-41.

46.Busam KJ, Iversen K, Koplan KA, Old LJ, Berwick M, Spagnoli GC, Jungbluth AA. Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma. Frequency of expression and correlation with prognostic parameters. Modern Pathology 2000;13:459-65.

47.Vaughan TL, Stewart PA, Teschke K, Lynch CF, Swanson GM, Lyon JL, Berwick M. Occupational exposure to formaldehyde and wood dust and risk of nasopharyngeal carcinoma. Occupational and Environmental Medicine 2000;57:376-84.

48.Berwick M, Vineis P. Review of human epidemiologic studies of DNA repair and cancer. Journal of the National Cancer Institute; 2000, 92:11-23.

49.Brady MS, Oliveria SA, Christos PJ, Berwick M, Coit DG, Katz J, Halpern A. Patterns of detection in cutaneous melanoma-implications for secondary prevention. Cancer 2000; 89:342-7

50.Berwick M. Gene-environment interactions in melanoma: current status and new investigational strategies. Forum (Genova) 2000 10(3):191-200.

15

51.Christos PJ, Oliveria SA, Halpern AC, Fine JA, Barnhill RL, Berwick M. Signs and symptoms of melanoma in older populations. J Clin Epidemiol 2000;53(10):1044-1053.

52.Busam K, Antonescu CR, Nehal KS, Marghoob A A, Sachs DL, Shiu J, Berwick M. Histologic classification of tumor-infiltrating lymphocytes in primary cutaneous malignant melanoma: a study of inter-observer agreement. American Journal of Clinical Pathology 2001; 115:856-60.

53.Pierce AJ, Stark J, Araujo FP, Moynahan ME, Berwick M, Jasin M. Double-strand breaks and tumorigenesis. Trends in Cell Biology, 2001:11:S52-9.

54.Wang SQ, Setlow R, Berwick M, Polsky D, Marghoob AA, Kopf AW, Bart RS. Ultraviolet A and Melanoma: a Review. Journal of the American Academy of Dermatology 2001; 44:837-46

55.Berwick M, Song YS, Jordan R, Brady MS, Orlow I. Mutagen sensitivity as an indicator of soft tissue sarcoma risk. Environ Mol Mutagen 2001:38:223-226 .

56.Oliveria S, Dusza S, Berwick M. Issues in the Epidemiology of Melanoma. Expert Review in Anticancer Ther. 2001; 1(3):453-459.

57.Orlow I, Roy P, Barz A, Canchola R, Song Y, Begg CB, Berwick M. Validation of a rapid detection method-denaturing high performance liquid chromatography (DHPLC) for the identification of human INK4A gene mutations. J Mol Diag 2001; 3:158-163.

58.Dwyer T, Blizzard L, Ashbolt R, Berwick M, Plumb J. Cutaneous melanin density measured by spectrophotometry and risk of malignant melanoma, basal cell carcinoma and squamous cell carcinoma of the skin. American Journal of Epidemiology 2002;155(7):614-21.

59.Mahabir S, Coit D, Liebes L, Brady MS, Lewis JJ, Roush G, Nestle M, Fry, D, Berwick M. Randomized, placebo-controlled trial of dietary supplementation of alpha-tocopherol on mutagen sensitivity levels in melanoma patients: a pilot trial. Melanoma Research 2002; 12:83-90.

60.Lohmann CM, Coit DG, Brady MS, Berwick M, Busam KJ. Sentinel lymph node biopsy in patients with diagnostically controversial melanocytic tumors. Am J Surg Pathol 2002 16:47-55.

61.Qin J, Berwick M, Ashbolt R, Dwyer T. Quantifying the change of melanoma incidence by Breslow thickness. Biometrics 2002, 58(3):665-70.

62.Lohmann CM, Iversen K, Jungluth AA, Berwick M, Busam KJ. Expression of melanocyte differentiation antigens and ki-67 in nodal nevi and comparison of ki-67 expression with metastatic melanoma. Am J Surg Pathol 2002;26:1351-7.

16

63.Stellman SD, Y Chen, JE Muscat, MV Djordjevic, JP Richie Jr, P. Lazarus, S Thompson N Altorki, M Berwick, ML Citron, S Harlap, T Kaur, AI Neugut, S Olson, JM Travaline, P Witorsch, Z-F Zhang. Lung cancer risk in white and black Americans. Ann Epidemiol 2003;13(4):294-302.

64.Huynh PM, Glusac EJ, Alvarez-Franco M, Berwick M, Bolognia J. Numerous small darkly pigmented melanocytic nevi: The cheetah phenotype. Journal of the American Academy of Dermatology. 2003; 48(5):707-13.

65.Kutler DI, Singh B, Satagopan J, Batish, D, Berwick M, Giampietro PF, Auerbach AD. A twenty year perspective of the International Fanconi Anemia Registry. Blood 2003;101:1249-1256.

66.Negin B, Riedel E, Oliveria SA, Berwick M, Coit DG, Brady MS. Symptoms and signs of primary melanoma: important indicators of Breslow depth. Cancer 2003; 98(2):344-8.

67.Donat SM, Bayuga S, Herr HW, Berwick M. Fluid intake and the risk of tumor recurrence in patients with superficial bladder cancer. J Urology 2003 170 (5):1777-80.

68.Mahabir M, Frenkel K, Brady MS, Coit D, Leibes L, Karkoszka J, Roush G, Berwick M. Randomized, placebo-controlled trial of α-tocopherol supplementation on levels of autoantibodies against 5-hydroxymethyl-2-deoxyuridine (anti-HMdU Abs) in melanoma patients. Melanoma Research 2004, 14:49-56.

69.Berwick M, Orlow I, Mahabir S, Myskowski P, Coit D, Brady MS, Roy P, Song

YS, Canchola R, Barz A, Halpern A, Bolognia J, Eng S, Elahi A, Begg CBB. Estimating the relative risk of developing melanoma in INK4A carriers. European J Cancer Prevention, 2004 13 (1):65-70.

70.Dwyer T, Stankovich JM, Blizzard L, FitzGerald LM, Dickinson JL, Reilly A, Williamson J, Ashbolt R, Berwick M, Sale M. Does the addition of information on genotype improve the prediction of risk of melanoma and non-melanoma skin cancer beyond that obtained from skin phenotype? American Journal of Epidemiology 2004, 159(9):826-33.

71.Thomas NE, Alexander A, Edmiston SE, Parrish E, Millikan RC, Berwick M, Groben P, Ollila DW, Conway K. Tandem BRAF mutations in primary invasive melanomas. Journal of Investigative Dermatology 2004, 122(5):1245-50.

72.Weinstock MA, Risica PM, Martin RA, Rakowski W, Smith KJ, Berwick, M, Goldstein, MG, Lasater T. Reliability of assessment and circumstances of performance of thorough skin self-examination for the early detection of melanoma in the check-it-out project. Prev Med 2004;38:761-5.

17

73.Oliveria SA, Dusza SW, Phelan DL, Ostroff JS, Berwick M, Halpern AC. Patient adherence to skin self-examination: effect of nurse intervention with photographs. Am J Prev Med 2004,26(2):152-5.

74.Amend KL, Elder JT, Tomsho LP, Bonner JD, Johnson TM, Schwartz J, Berwick M, Gruber SB. EGF gene polymorphism and the risk of incident primary melanoma. Cancer Research 2004, 64:2668-72.

75.Ford JS, Ostroff JS, Hay JL, Buckley TR, Stein TR, Berwick M, Primavera LH, Shike M. Participation in annual skin cancer screening among women seeking routine mammography. Prev Med 2004;38:704-12.

76.Satagopan JM, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach AD. A note on competing risks in survival data analysis. British Medical Journal August 10, 2004. 91(7):1229-35. Review. PMID: 15305188

77.Berwick M, Matullo G, Song YS, Guarrera S, Dominguez G, Cordon-Cardo C, Orlow I, Vineis P. Association between AhR genotype and survival in soft tissue sarcoma. J Clin Oncol 2004; 22:3997-4001.

78.Azfar R, Schwartz RA, Berwick M. Primary melanoma prevention and the role of the physician. Gital Dermatol Venereol 2004;139:1-6.

79.Lockett KL, Hall MC, Xu J, Zheng SL, Berwick M, Chuang S-C, Clark PE, Cramer SD, Lohman K, Hu JJ. The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function. Cancer Research 2004; 64(17):6344-8.

80.Begg CB, Hummer A, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Klotz JB, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Berwick M. Familial aggregation of melanoma risks in a large population-based sample of melanoma. Cancer Causes Control. 2004 Nov;15(9):957-65.

81.Berwick M, Armstrong BK, Ben-Porat L, Fine J, Kricker A, Eberle C, Barnhill R. Sun exposure and mortality from melanoma. J Natl Cancer Inst 2005;97(3):195-9.

82.Barnhill RL, Katzen J, Spatz A, Fine J, Berwick M. The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma. J Cutan Pathol. 2005;32(4):268-73.

83.Wiggins CL, Berwick M, Newton-Bishop J. Malignant Melanoma in Pregnancy.Obstet Gynecol Clin North Am. 2005 Dec;32(4):559-568.

84.Fisher NM, Schaffer JV, Berwick M, Bolognia JL. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior

18

skin biopsies and family history of melanoma. J Am Acad Dermatol. 2005 Sep;53(3):393-406.

85.Berwick M, Kesler D. Ultraviolet Radiation Exposure, Vitamin D, and Cancer.Photochem Photobiol. 2005; 81(6):1261-6. Review. PMID: 16164370

86.Ferrone CR, Ben Porat L, Panageas KS, Berwick M, Halpern AC, Patel A, Coit DG. Clinicopathological features of and risk factors for multiple primary melanomas. JAMA. 2005;294(13):1647-54.

87.Begg CB, Orlow I, Hummer AJ, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Mitra N, Busam K, From L, Berwick M: Genes Environment and Melanoma Study Group. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. J Natl Cancer Inst. 2005;97(20):1507-15.

88.Millikan RC, Hummer A, Begg C, Player J, de Cotret AR, Winkel S, Mohrenweiser H, Thomas N, Arstrong B, Kricker A, Marrett LD, Gruber SB, Anton-Culber H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck T, Busam K, From L, Mujumdar U, Berwick M. Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma study. Carcinogenesis. 2006; 27(3):610-618.

89.Hay J, Ostroff J, Martin A, Serle N, Soma S, Mujumdar U, Berwick M. Skin cancer risk discussions in melanoma-affected families. J Cancer Educ 2005; 20(4):240-6.

90.Wood SR, Berwick M, Ley RD, Walter RB, Setlow RB, Timmins GS. UV causation of melanoma in Xiphophorus is dominated by melanin photosensitized oxidant production. PNAS 2006;103(11):4111-41115.

91.Begg CB, Hummer AJ, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Culver HA, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Busam K, From L. Berwick M for the GEM Study Team. A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma. Int J Epidemiol. 2006, 35(3):756-64.

92.Smith HO, Berwick M, Verschraegen CF, Wiggins C, Lansing L, Muller CY, Qualls CR. Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol 2006;107(5):1075-1085.

93.Manguerra M, Saletta F, Karagas MR, Berwick M, Veglia F, Vineis P, Matullo G. XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review. Am J Epidemiol. 2006, 164:297-302.

94.Erdei S, Lee SJ, Wei Q, Wang LE, Song YS, Bovbjerg D, Berwick M. Reliability of mutagen sensitivity assay: an inter-laboratory comparison. Mutagenesis 2006; 21:261-4.

19

95.Berwick M, Orlow I, Hummer AJ, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Busam K, From L, Mujumdar U, Wilcox H, Begg CB and The GEM Study Group. The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: An international population-based study. Cancer Epidemiol Biomarkers Prev 2006;15(8):1-6.

96.Thomas NE, Berwick M, Cordeiro Stone M. Could BRAF mutations in melanocytic lesions arise from DNA damage induced by ultraviolet radiation? J Invest Dermatol; 2006;126(8):1693-6.

97.Kanetsky PA, Rebbeck TR, Hummer AJ, Panossian S, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Culver HA, Zanetti R, Gallagher RP, Dwyer T, Busam K, From L, Mujumdar U, Wilcox H, Begg CB, Berwick M. and the GEM Study Group. Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma. Cancer Res 2006;66:9330-7.

98.Vineis P, Berwick M. The population dynamics of cancer: a Darwinian perspective. Int J Epidemiol 2006, 35(5):1151-9.

99.Kricker A, Armstrong BK, Goumas C, Litchfield M, Begg CB, Hummer AJ, Marrett LD, Theis B, Millikan RC, Thomas N, Culver HA, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Busam K, From L, Mujumdar U, Zanetti R, Berwick M; for the GEM Study Group. Ambient UV, personal sun exposure and risk of multiple primary melanomas. Cancer Causes Control. 2007 Apr;18(3):295-304.

100. Orlow I, Begg CB, Cotignola J, Roy P, Hummer AJ, Clas BA, Mujumdar U, Canchola R, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Wilcox H, Busam K, From L, Berwick M. CDKN2A Germline Mutations in Individuals with Cutaneous Malignant Melanoma. J Invest Dermatol. 2007: 127:1234-43.

101.Cotignola J, Reva B, Mitra N, Ishill N, Chuai S, Patel A, Shah S, Vanderbeek G, Coit D, Busam K, Halpern A, Houghton A, Sander C, Berwick M, Orlow I. Matrix Metalloproteinase-9 (MMP-9) polymorphisms in patients with cutaneous malignant melanoma. BMC Med Genet. 2007;8(1):10.

102.Kalb R, Neveling K, Hoehn H, Schneider H, Linka Y, Batish SD, Hunt C, Berwick M, Callen E, Surrales J, Casado JA, Bueren J, Dasi A, Soulier J, Gluckman E, Zunan CM, van Spaendonk R, Pals G, de Winter JP, Joenje H, Grompe M, Auerbach AD, Hanenberg H, Schindler D. Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype. Am J Hum Genet 2007; 80(5):895-910.

20

103. Lea SC, Scotto JA, Buffler PA, Fine J, Barnhill RL, Berwick M. Ambient UVB and melanoma risk in the United States: a case-control analysis. Anal Epidemiol 2007; 17(6):447-53.

104. Thomas NE, Edmiston SN, Alexander A, Millikan RC, Groben PA, Hao H, Tolbert D, Berwick M, Busam K, Begg CB, Mattingly D, Ollila DW, Tse CK, Hummer A, Lee-Taylor J, Conway K. Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanomas. Cancer Epidemiol Biomarkers Prev 2007;16(5).

105. Weinstock MA, Risica PM, Martin RA, Rakowski W, Dube C, Berwick M, Goldstein MG, Acharyya S, Lasater T.Melanoma early detection with thorough skin self-examination: the "Check It Out" randomized trial. Am J Prev Med. 2007 Jun;32(6):517-24.

106. Stitzenberg KB, Thomas NE, Dalton K, Brier SE, Ollila DW, Berwick M, Mattingly D, Millikan RC.Distance to diagnosing provider as a measure of access for patients with melanoma. Arch Dermatol. 2007;143(8):991-8.

107. Lachiewicz AM, Berwick M, Wiggins CL, Thomas NE.Epidemiologic Support for Melanoma Heterogeneity Using the Surveillance, Epidemiology, and End Results Program. J Invest Dermatol. 2007 Aug 23;

108. Berwick M, Satagopan JM, Ben-Porat L, Carlson A, Mah K, Henry R, Diotti R, Milton K, Pujara K, Landers T, Dev Batish S, Morales J, Schindler D, Hanenberg H, Hromas R, Levran O, Auerbach AD. Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer. Cancer Res. 2007 Oct 1;67(19):9591-6.

109. Berwick M. Counterpoint: sunscreen use is a safe and effective approach to skin cancer prevention. Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):1923-4.

110. Olsen CM, Green AC, Zens MS, Stukel TA, Bataille V, Berwick M, Elwood JM, Gallagher R, Holly EA, Kirkpatrick C, Mack T, Osterlind A, Rosso S, Swerdlow AJ, Karagas MR. Anthropometric factors and risk of melanoma in women: a pooled analysis. Int J Cancer 2008;122(5):1100-8.

111. Hay JL, Meischke HS, Bowen DJ, Majer J, Shoveller J, Press N, Asgari M, Berwick M, Burke W. Anticipating dissemination of cancer genomics in public health: a theoretical approach to psychosocial and behavioral challenges. Ann Behav Med 2007;34(3):275-286.

112. Herlyn M, Halaban R, Ronai Z, Schuchter L, Berwick M, Pinkel D. Roadmap for new opportunities in melanoma research. Semin Oncol 2007;34(6):566-76.

113. Barnhill RL, Argenyi Z, Berwick M, Duray PH, Erickson L. Guitart J, Horenstein MG, Lowe L, Messina J, Paine S, Piepkorn MW, Prieto V, Rabkin MS, Schmidt B, Selim A. Shea CR, Trotter MJ. Atypical cellular blue nevi (cellular blue nevi

21

with atypical features): Lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma (“Malignant Blue Nevus”). Am J Surg Pathol 2008;32(1):36-44.

114. Capanu M, Orlow I, Berwick M, Hummer AJ, Thomas DC, Begg CB. The use of hierarchical models for estimating relative risks of individual genetic variants: An application to a study of melanoma. Stat Med. 2008; 27(11):1973-92. PMID: 18335566

115. Berwick M, Lachiewicz A, Pestak C, Thomas NE. Solar UV exposure and mortality from skin tumors. Adv Exp Med Biol. 2008;624:117-24.

116. Lachiewicz A, Berwick M, Wiggins CL, Thomas NE. Epidemiologic support for melanoma heterogeneity using the surveillance, epidemiology, and end results program. J Invest Dermatol. 2008;128(5):1340-2.

117. Lachiewicz A, Berwick M, Wiggins CL, Thomas NE. Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program. Arch Dermatol. 2008;144(4):515-21.

118. Hay J, Shuk E, Brady MS, Berwick M, Ostroff J, Halpern A. Family communication after melanoma diagnosis. Arch Dermatol. 2008 Apr;144(4):553-4.

119. Orlow I, Park BJ, Mujumdar U, Patel H, Siu-Lau P, Clas BA, Downey R, Flores R, Bains M, Rizk N, Dominguez G, Jani J, Berwick M, Begg CB, Kris MG, Rusch VW. DNA damage and repair capacity in patients with lung cancer: prediction of multiple primary tumors. J Clin Oncol. 2008 Jul 20;26(21):3560-6.

120. Chang YM, Newton-Bishop JA, Bishop DT, Armstrong BK, Bataille V, Bergman W, Berwick M, Bracci PM, Elwood JM, Ernstoff MS, Green AC, Gruis NA, Holly EA, Ingvar C, Kanetsky PA, Karagas MR, Marchand LL, Mackie RM, Olsson H, Osterlind A, Rebbeck TR, Reich K, Sasieni P, Siskind V, Swerdlow AJ, Titus-Ernstoff L, Zens MS, Ziegler A, Barrett JH.A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes. Int J Cancer. Jan 2009, 124(2):420-8. PMID: 18792098 .

121. Sood A, Qualls C, Seagrave J, Stidley C, Berwick M, Archibeque T, Schuyler M. Effect of Specific Allergen Inhalation on Serum Adiponectin in Human Asthma. Chest. Feb 2009. 135(2):287-94. PMID: 18812451.

122. Berwick M. Are tanning beds "safe"? Human studies of melanoma. Pigment Cell and Melanoma Research 2008. 21(5):517-9.PMID: 18821856

123. Oliveria SA, Satagopan JM, Geller AC, Dusza SW, Weinstock MA, Berwick M, Bishop M, Heneghan MK, Halpern AC. Study of Nevi in Children (SONIC):

22

Baseline Findings and Predictors of Nevus Count. Am J Epidemiol. Jan 2009;169(1):41-53 PMID: 19001133

124. Olsen CM, Zens MS, Stukel TA, Sacerdote C, Chang YM, Armstrong BK, Bataille V, Berwick M, Elwood JM, Holly EA, Kirkpatrick C, Mack T, Bishop JN, Østerlind A, Swerdlow AJ, Zanetti R, Green AC, Karagas MR, Whiteman DC. Nevus density and melanoma risk in women: a pooled analysis to test the divergent pathway hypothesis. Int J Cancer. Feb 2009;124(4):937-44. PMID: 19035450

125. Mujumdar UJ, Hay JL, Monroe-Hinds YC, Hummer AJ, Begg CB, Wilcox HB, Oliveria SA, Berwick M. Sun protection and skin self-examination in melanoma survivors. Psychooncology. Oct 2009; 18(10):1106-15. PMID: 19142859

126. Berwick M, Erdei E, Hay J. Melanoma epidemiology and public health. Dermatol Clin. April 2009;27(2):205-14.

127. Orlow I, Tommasi DV, Bloom B, Ostrovnaya I, Cotignola J, Mujumdar U, Busam KJ, Jungbluth AA, Scolyer RA, Thompson JF, Armstrong BK, Berwick M, Thomas NE, Begg CB. Evaluation of the Clonal Origin of Multiple Primary Melanomas Using Molecular Profiling. J Invest Dermatol. Aug 2009; 129(8):1972-82. PMID: 19282844

128. Chang YM, Barrett JH, Bishop DT, Armstrong BK, Bataille V, Bergman W, Berwick M, Bracci PM, Elwood JM, Ernstoff MS, Gallagher RP, Green AC, Gruis NA, Holly EA, Ingvar C, Kanetsky PA, Karagas MR, Lee TK, Marchand LL, Mackie RM, Olsson H, Osterlind A, Rebbeck TR, Sasieni P, Siskind V, Swerdlow AJ, Titus-Ernstoff L, Zens MS, Newton-Bishop JA. Sun exposure and melanoma risk at different latitudes: A pooled analysis of 5700 cases and 7216 controls. Int J Epidemiol. Jun 2009; 38(3):814-30. PMID: 19359257.

129. Scope A, Marghoob AA, Chen CS, Lieb JA, Weinstock MA, Halpern AC; SONIC Study Group. Dermoscopic patterns and subclinical melanocytic nests in normal-appearing skin. Br J Dermatol. Jun 2009; 160(6):1318-21. PMID: 19416274.

130. Lauer FT, Mitchell LA, Bedrick E, McDonald JD, Lee WY, Li WW, Olvera H, Amaya MA, Berwick M, Gonzales M, Currey R, Pingitore NE Jr, Burchiel SW. Temporal-spatial analysis of U.S.-Mexico border environmental fine and coarse PM air sample extract activity in human bronchial epithelial cells. Toxicol Appl Pharmacol. Jul 2009;238(1):1-10. PMID: 19410595

131. Yang J, Guo H, Gallazzi F, Berwick M, Padilla RS, Miao Y. Evaluation of a Novel Arg-Gly-Asp-Conjugated alpha-Melanocyte Stimulating Hormone Hybrid Peptide for Potential Melanoma Therapy. Bioconjug Chem. 2009 Jun 24. [Epub ahead of print]. PMID: 19552406.

132. Thomas NE, Kanetsky PA, Edmiston SN, Alexander A, Begg CB, Groben PA, Hao H, Busam K, Ollila DW, Berwick M, Conway K. Relationship between

23

Germline MC1R Variants and BRAF-Mutant Melanoma in a North Carolina Population-Based Study. J Invest Dermatol. 2010 May;130(5):1463-5.

133. Erdei E, Kang H, Meisner A, White K, Pickett G, Baca C, Royce M, Berwick M. Polymorphisms in cytokine genes and serum cytokine levels among New Mexican women with and without breast cancer. Cytokine. 2010;51(1):18-24. Epub 2010 Apr 24.PMID: 20418110

134. Thomas NE, Kanetsky PA, Begg CB, Conway K, Berwick M. Melanoma molecular subtypes: unifying and paradoxical results. J Invest Dermatol. 2010 Jan;130(1):12-4.

135. Lazovich D, Vogel RI, Berwick M, Weinstock MA, Anderson KE, Warshaw EM. Indoor tanning and risk of melanoma: A case-control study in a highly exposed population. Cancer Epidemiol Biomarkers Prev 2010, ep pub ahead of print. PMID 20507845.

136. Kricker A, Armstrong BK, Goumas C, Kanetsky P, Gallagher RP, Begg CB, Millikan RC, Dwyer T, Rosso S, Marrett LD, Thomas NE, Berwick M; GEM Study Group. MC1R genotype may modify the effect of sun exposure on melanoma risk in the GEM study. Cancer Causes Control. 2010 21:2137-47.

137. Yang J, Guo H, Padilla RS, Berwick M, Miao Y.Replacement of the Lys linker with an Arg linker resulting in improved melanoma uptake and reduced renal uptake of Tc-99m-labeled Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptide. Bioorg Med Chem. 2010 Aug 1. [Epub ahead of print]

138. Olsen CM, Zens MS, Green AC, Stukel TA, Holman CD, Mack T, Elwood JM, Holly EA, Sacerdote C, Gallagher R, Swerdlow AJ, Armstrong BK, Rosso S, Kirkpatrick C, Zanetti R, Bishop JN, Bataille V, Chang YM, Mackie R, Osterlind A, Berwick M, Karagas MR, Whiteman DC. Biologic markers of sun exposure and melanoma risk in women: Pooled case-control analysis. Int J Cancer. 2010 Sep 20. [Epub ahead of print]PMID: 20857492

139. Berwick M. Invited commentary: a sunbed epidemic? Am J Epidemiol. 2010 Oct 1;172(7):768-70; discussion 771-772. Epub 2010 Sep 2. Review.PMID: 20813800.

140. Thomas NE, Kricker A, From L, Busam KJ, Millikan RC, Ritchey ME, Armstrong BK, Lee-Taylor J, Marrett L, Anton-Culver H, Zanetti R, Rosso S, Gallagher RP, Dwyer T, Goumas C, Kanetsky PA, Begg CB, Orlow I, Wilcox H, Paine S, Berwick M. Associations of cumulative sun exposure and phenotypic characteristics with histologic solar elastosis. Cancer Epidemiol Biomarkers Prev. 2010 ; 19:2932-41. PMID: 20802019

141. Olsen CM, Zens MS, Green AC, Stukel TA, Holman CD, Mack T, Elwood JM, Holly EA, Sacerdote C, Gallagher R, Swerdlow AJ, Armstrong BK, Rosso S,

24

Kirkpatrick C, Zanetti R, Bishop JN, Bataille V, Chang YM, Mackie R, Osterlind A, Berwick M, Karagas MR, Whiteman DC. Biologic markers of sun exposure and melanoma risk in women: Pooled case-control analysis.Int J Cancer. 2010 Sep 20. [Epub ahead of print]PMID: 20857492.

142. Red hair or not--reassessment of melanoma risk among CDKN2A carriers.Berwick M. Pigment Cell Melanoma Res. 2011 Feb;24(1):9-10. No abstract available. PMID: 21118390.

143. The good, the bad, and the ugly of sunscreens. Berwick M. Clin Pharmacol Ther. 2011 Jan;89(1):31-3.PMID: 21170070 .

144. Orlow I, Roy P, Reiner AS, Yoo S, Patel H, Paine S, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Thomas NE, Gruber SB, Anton-Culver H, Rosso S, Gallagher RP, Dwyer T, Kanetsky PA, Busam K, From L, Begg CB, Berwick M; for the GEM Study Group. Vitamin D receptor polymorphisms in patients with cutaneous melanoma. Int J Cancer. 2011; 130:405-18. PMID: 1365644.

145. Conway K, Edmiston SN, Khondker ZS, Groben PA, Zhou X, Chu H, Kuan PF, Hao H, Carson C, Berwick M, Olilla DW, Thomas NE. DNA-methylation profiling distinguishes malignant melanomas from benign nevi. Pigment Cell Melanoma Res. 2011;24(2):352-360. PMID:21375697.

146. Berwick M. Can UV Exposure Reduce Mortality? Cancer Epidemiol Biomarkers Prev. 2011;20(4):582-4. PMID:21454422.

147. Barnhill RL, Busam KJ, From L, Bagot M, Lugassy C, Berwick M. Inter-observer concordance for the recognition of angiotropism in human melanoma. Pigment Cell Melanoma Res 2011; 24:582-3. PMID: 21466662.

148. Mandelcorn-Monson R, Marrett L, Kricker A, Armstrong BK, Orlow I. Goumas C, Paine S. Rosso S, Thomas N, Millikan RC, Pole JD, Cotignola J, Rosen C, Kanetsky PA, Lee-Taylor J, Begg CB, Berwick M. Sun exposure, vitamin D receptor polymorphisms FokI and BsmI and risk of multiple primary melanoma. Cancer Epidemiol. 2011; 35:e105-10. PMID 21612999

149. Berwick M, Begg CB, Armstrong BK, Reiner AS, Thomas NE, Cook LS, Orlow I, Kricker A, Marrett LD, Gruber SB, Anton-Culber H, Millikan RC, Gallagher RP, Dwyer T, Rosso S, Kanetsky PA, Lee-Taylor J. Interaction of CDKN2A and sun exposure in the etiology of melanoma in the general population. J Invest Dermatol 2011;131:2500-3. PMID: 21857749

150. Satagopan JM, Zhou Q, Oliveria SA, Dusza SW, Weinstock MA, Berwick M, Halpern AC. Properties of preliminary test estimators and shrinkage estimators for evaluating multiple exposures – Application to questionnaire data from the SONIC study. J R Stat Soc Ser C Appl Stat 2011; 60:619-632. PMID 21857749

25

151. Erdei E, Sheng H, Maestas E, Mackey A, White KA, Li L, Dong Y, Taylor J, Berwick M, Morse DE. Self-reported ethnicity and genetic ancestry in relation to oral cancer and pre-cancer in Puerto Rico. PLoS One 2011;6:323950. PMID 218997864

152. Murali R, Goumas C, Kricker A, From L, Busam KJ, Begg CB, Dwyer T, Gruber SB, Kanetsky PA, Orlow I, Rosso S, Thomas NE, Berwick M, Scolyer RA, Armstrong BK; For the GEM Study Group. Clinicopathologic features of incident and subsequent tumors in patients with multiple primary cutaneous melanomas. Ann Surg Oncol 2012; 19:1024-33. PMID 21913010

153. Lazovich D, Vogel RI, Berwick M, Weinstock MA, Warshoaw EM, Anderson KE. Melanoma risk in relation to use of sunscreen or other sun protection methods. Cancer Epidemiol Biomarkers Prev 2011;20:2583-93. PMID 22016471

154. Yue J, Lu H, Liu J, Berwick M, Shen Z. Filamin-A as a marker and target for DNA damage based cancer therapy. DNA Repair (Amst) 2011; 11:192-200. PMID 22051193

155. Dusza SW, Halpern AC, Satagopan JM, Oliveria SA, Weinstock MA, Scope A, Berwick M, Geller AC. Prospective study of sunburn and sun behavior patterns during adolescence. Pediatrics 2012;129:309-17. PMID 22271688

156. Olvera HA, Garcia M, Li WW, Yang H, Amaya MA, Myers O, Burchiel SW, Berwick M, Pingitore NE Jr. Principal component analysis optimization of a PM(2.5) land use regression model with small monitoring network. Sci Total Environ. 2012 (epub ahead of print). PMID 22464030

157. Mukherjee B, Delancey JO, Raskin L, Everett J, Jeter J, Begg CB, Orlow I, Berwick M, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Culver HA, Rosso S, Zanetti R, Kanetsky PA, From L, Gruber SB; for the GEM Study Investigators. Risk of Non-Melanoma Cancers in First-Degree Relatives of CDKN2A Mutation Carriers. J Natl Cancer Inst. 2012;104:953-6. PMID 22534780

158. Flores K, Stidley CA, Mackey AJ, Picchi MA, Stabler SP, Siegfried JM, Byrs T, Berwick M, Belinsky SA, Leng S. Sex-specific association of sequence variants in CBS and MTRR with risk for promoter hypermethylation in the lung epithelium of smokers. Carcinogenesis 2012; 33:1542-7. PMID 2265368

159. Gonzales M, Myers O, Smith L, Olvera HA, Mukerjee S, Li WW, Pingitore N, Amaya M, Burchiel S, Berwick M; ARCH Study Team. Evaluation of land use regression models for NO(2) in El Paso, Teas, USA. Sci Total Environ 2012; 432:135-142. PMID 22728301

160. Olvera HA, Perez D, Clague JW, Cheng YS, Li WW, Amaya MA, Burchiel SW, Berwick M, Pingitore NE. The effect of ventilation, age and asthmatic condition

26

on ultrafine particle deposition in children. Pulm Med 2012. Epub 2012 Jul 11. PMID 22848818

161. Berwick M. How do solar UV irradiance and smoking impact the diagnosis of second cancers after diagnosis of melanoma? No answer yet. Dermatoendocrinol 2012, 4:18-19. PMID 22870348

162. Hay JL, Baguer C, Li Y, Orlow I, Berwick M. Interpretation of melanoma risk feedback in first-degree relatives of melanoma patients. J Cancer Epidemiol 2012; 2012:374842. PMID 22888347

163. Tran AD, Aalborg J, Askigian NL, Morelli JG, Mokrohisky ST, Dellavalle RP, Berwick M, Box NF, Crane LA. Parent’s perceptions of skin cancer threat and children’s physical activity. Prev Chronic Dis 2012; E143. PMID 22935145.

164. Sondak VK, Swetter SM, Berwick M. Gender disparities in patients with melanoma: breaking the glass ceiling. J Clin Oncol. 2012;30:2177-8. PMID 22547593

165. Berwick M, Erdei E. Vitamin D and melanoma incidence and mortality. Pigment Cell Melanoma Res 2013. 26(1):9-15. PMID 22947439

Review articles and articles appearing as chapters in edited volumes:

1. Stolwijk JAJ, Leaderer BP, Berwick M. Experimental considerations in the measurement of exposures to sidestream cigarette smoke. (Eds. D.R.B. Gammage and S.V. Kaye). Indoor Air and Human Health, Lewis Publishing, Inc. Chelsea, MI, 1985, Ch.15:205-214.

2. Berwick M. The Ecology of the Maldhari Graziers in the Gir Forest, India. Journal of the Bombay Natural History Society, 1986.

3. Roush GC, Berwick M, Mackie R, Koh H. Screening for cutaneous malignant melanoma. IN Cutaneous Melanoma (Eds. C. Balch, A. Houghton, A. Sober, G. Milton, S. Soong.) 1992: 70-81. Lippincott Co, Philadelphia.

4. Berwick M, Dubin N, Barnhill RL, Roush GC. Skin self-examination and lethal melanoma: preliminary analyses. In Epidemiologic Aspects of Cutaneous Malignant Melanoma, (Eds. Gallagher, R.P., Elwood J.M.) Kluwer Academic Publishers, Boston, 1994, pp.266-272.

5. Berwick M, Chen Y-t. Authors reply to letter to the editor: Re: Reliability of reported sunburn history in a case-control study of cutaneous malignant melanoma. American Journal of Epidemiology 1996;144 (7) 707.

27

6. Berwick M, Chen YT. Re-reliability of reported sunburn history in a case-control study of cutaneous malignant-melanoma - reply (Letter). American Journal of Epidemiology 1998;148:620-621.

7. Berwick M. Epidemiology of Melanoma. In: Cutaneous Melanoma (Eds. C. Balch. A. Houghton, A. Sober, G. Milton, S. Soong) Third Edition, 1998; Quality Medical Publishing St. Louis, MO, 1998.

8. Berwick M. Sun exposure and cancer. IN Textbook of Psycho-Oncology (Ed. J. Holland), 1998; Oxford Press, New York, NY

9. Berwick M. Multiple Primary Skin Cancers. IN Neugut AI, Robinson E, Meadows AT (Eds.) Multiple Primary Cancers. Lippincott Williams and Wilkins, 1999, New York.

10.Gasparro F, Berwick M. Re: Sunscreen use, wearing clothes, and the number of nevi in 6-to-7-year-old European children. Letter. Journal of the National Cancer Institute 1999;91:1078-1080.

11.Grossman LG, Matanoski G, Farmer E, Hedyati M, Ray S, Trock B, Hanfelt J, Roush G, Berwick M, Hu J. DNA Repair as a susceptibility factor in chronic diseases in human populations. In Advances in DNA Damage and Repair (ed Dizdaroglu and Karakaya). Kluwer Academic/Plenum Publishers, New York, 1999.

12.Berwick M. Why are people still dying from melanoma? Editorial. Archives of Dermatology 1999. 135:1534-1536.

13.Berwick M, Vineis P. Authors reply to letter re: Review of human epidemiologic studies of DNA repair and cancer. Journal of the National Cancer Institute; 2000, 92.

14.Berwick M. Patterns of sun exposure that are important in melanoma. In Newton-Bishop J, Dore J. Challenges in Melanoma. 2002. Blackwell Scientific Publishers, Oxford University. Pp3-15.

15.Berwick M, Weinstock M. Descriptive epidemiology of melanoma. IN Cutaneous Melanoma, ed. 4, 2002, Quality Medical Publishing, New York.

16.Berwick M, Matullo G, Vineis P. DNA repair as a biomarker. IN Wilson S, Suk, W. Technology-Driven Biomarker Development Application in Environmentally-Associated Diseases. Ch. 7, CRC Press, 2002

17.Gasparro F, Berwick M, Mitchnick M, Diffey B, Nash J, Mitchel D, Young A, Knowland J, Seykora J, Brown D. Godar D. Sun protective agents: formulations, effects and side effects. IN Katz Fitzpatrick T, Dermatology in General Medicine, 6th Edition. , Medical Publishing Division, McGraw-Hill, New York. 2002.

28

18.Berwick M. Soft Tissue Sarcoma. IN Schottenfeld D, Fraumeni J, Cancer Epidemiology and Prevention, Third Edition. 2005.

19.Lazovich D, Sweeney C, Weinstock MA, Berwick M. Re: A prospective study of pigmentation, sun exposure and risk of cutaneous malignant melanoma in women. (letter) J Natl Cancer Inst 2004; 96(4):335.

20.Vineis P, Matullo G, Berwick M. Molecular Epidemiology. IN Handbook of Epidemiology (Eds. Ahrens W, Pigeot I). 2005. Springer, New York.

21.Berwick M, Wiggins C. The current epidemiology of cutaneous malignant melanoma. Front Biosci 2006 May 1:11:1244-54. Review.

22.Berwick M. Biomarkers of DNA Repair. IN Vineis P and Wild C, Biomarkers in Epidemiology. Wiley, 2006.

23.Gonzales M, Erdei E, Berwick M. The Epidemiology of Skin Cancer. IN Nouri, Skin Cancer, 2008

24.Berwick M. Education and Public Awareness of Skin Cancer. IN Nouri, Skin Cancer, 2008.

25.Berwick M. UV Radiation in Melanoma Development and Pathogenesis. IN Agarwala and Sondak, Melanoma: Translational Research and Emerging Therapies 2008.

26. Torres S, Berwick M. Melanoma and Skin Aging. IN Chandy A, (Ed) Textbook of Aging Skin , Springer, 2009.

27. Torres S, Erdei E, Berwick M, Matullo G, Vineis P. Molecular Epidemiology, IN Wild C (Ed). Textbook of Epidemiology, xxx press, 2012.

28.Berwick M. The Epidemiology of Melanoma -2011. IN Bosserhoff A (Ed) Melanoma Epidemiology

Other writings and scholarly products:

1. Berwick M. Invited commentary: a sunbed epidemic? Am J Epidemiol. 2010: 172:768-70. Epub 2010 Sep2. PMID 20813800

2. Berwick M. Commentary: Sunscreens: The good, the bad and the ugly. Clinical Pharmacology and Therapeutics, 2010, in press.

3. Berwick M. Pathways to the development of melanoma: a complex issue. J Invest Dermatol 2006; 126:1932-3.

29

4. Berwick M. Melanoma: is more diagnosis better? J Gen Intern Med 2006 Jul:21(7):800. (invited editorial)

5. Matullo G, Berwick M, Vineis P. Gene-environment interactions: How many false positives? J National Cancer Inst 2005, 97(8): 550-1.(Invited editorial).

6. Berwick M. Toward misclassification in the biology of melanoma. J Invest Dermatol 2005;124(3):xiv. (Invited editorial)

7. Berwick M, Vineis P. Measuring DNA repair capacity: Small steps. J National Cancer Inst. 2005, 97 (2):84-85. (Invited editorial)

8. Lea C, Selvin S, Buffler PA, Scotto J, Berwick M. Quantifying lifetime exposure to ultraviolet radiation in the epidemiology of cutaneous malignant melanoma: a pilot study. Report LBL-32745, UC-600, NTIS, Springfield, VA 22161.

9. Berwick M, Bolognia JL, Fine JA, Simpson P, Jasmin M. Educating parents to limit sun exposure of newborns. Results of a study. Journal of the Skin Cancer Foundation May 1991.

10.Berwick M. Early detection and lethal melanoma. Summary. Chronic Diseases in Canada (Supplement), 1992;13(5):27-28.

11.Video. "Know Your Spots" - to encourage awareness of melanoma and skin self-examination. Distributed to dermatologists, hospitals, and melanoma epidemiologists, worldwide.

12.Mahabir S, Berwick M. What dietetics can learn from molecular biology. Letter - Journal of the American Dietetics Association 95 (7): 748-749.

13.Berwick M. Prevention of mortality from melanoma: skin self-examination. The Melanoma Letter, 1996.

14.Berwick M. Worldwide Incidence and Mortality: Rising or Falling? The 1998 Skin Cancer Foundation Journal, 40-42.

15.Mahabir S, Berwick M. Sunscreen, Sun Exposure, and Vitamin D: Where is the Balance? Mature Medicine, Canada, 1998.

Invited presentations at professional meetings:

1. Early Detection and Lethal Melanoma: Preliminary Results. Second Symposium on the Epidemiology of Melanoma and Non-Melanocytic Skin Cancer, Vancouver, BC, 1991.

2. Screening and Melanoma, Health Effects of Ultraviolet Radiation, Ottawa, Ontario, 1992.

30

3. Sunscreens in the 21st Century: How will ozone depletion affect their use. American Society of Photobiology, Marcos Island, FL, 1992.

4. Epidemiology of Melanoma: The Contribution of Sun Exposure and Early Detection. American Society of Photobiology, Chicago, Il, 1993.

5. Screening for Cutaneous Melanoma. World Conference for Cancer Organizations, Melbourne, Australia, 1996.

6. Screening for Cutaneous Melanoa: An Update. Third Symposium on the Epidemiology of Melanoma and Non-Melanocytic Skin Cancer, Vancouver, BC, 1996

7. Sunscreens and Skin Cancer: The Epidemiologic Evidence. AAAS Symposium. Philadelphia, PA 1998.

8. Risk Assessment: From Molecules to Humans and Vice Versa. Rischio e ambiente. Turin, Italy 1998.

9. UV and Melanoma: The Sunscreen Perspective. American Society for Photobiology. Snowbird, Utah. 1998.

10.The Role of Sunburn in Carcinogenesis. NIAMS Workshop on Risks and Benefits of Exposure to Ultraviolet Radiation and Tanning, Bethesda, MD. 1998.

11.The Epidemiology of Cancer Induction by Natural and Artificial Light Sources. American Society for Photobiology, Washington, DC. 1999.

12.Precursor Lesions for Melanoma, Special Symposia on Precursor Lesions, Society for Epidemiologic Research, Seattle, WA. 2000.

13.Gene-Environment Interactions in Melanoma, American Society for Photobiology, San Francisco, CA. 2000.

14.Melanoma and Sarcoma: Similarities and Differences. European Environmental Mutagenesis Society, 30th Annual Meeting, Budapest, Hungary. 2000.

15.Gene-Environment Interactions in Melanoma, Perspectives in Melanoma IV, Pittsburgh, PA. 2000.

16.Multiple Primary Melanoma – Melanoma Symposium, Society for Epidemiologic Research, Toronto, Canada. 2001.

17. Integration of DNA Repair and Epidemiologic Studies, Symposium on DNA Repair, University of North Carolina, Chapel Hill NC, 2001.

31

18. Molecular Epidemiology. ASCO-NCI Symposium on Molecular Medicine, Boston, MA. 2001.

19.Keynote Speech: NCI Workshop “Radiation Sensitivity, Cancer Susceptibility and Common DNA-Repair Polymorphisms” , Bethesda, MD. 2001.

20.The Current Epidemiology of Double Strand Break Repair: A Paradigm of Genotype-Phenotype Correlation and Challenge for the Future. Gordon Research Conference, Colby-Sawyer College, NH. 2001.

21.Keynote Speech: The Etiology of Skin Cancer, Vi Riunione Dell’Associzione Italiana Registri Tumori, Trento, Italy. 2002.

22.DNA Damage Responses. Special Symposium on DNA Repair. Society for Epidemiologic Research, Desert Springs, CA. 2002

23.Molecular Epidemiology. NCI-ASCO Scientific Symposium, Chicago, IL. 2002.

24.Melanoma: A Model for Gene-Environment Interaction, Seventeenth Annual Regional Cancer Symposium: Cancer in a Post-Genomic Era, Burlington, VT. 2002.

25.Gene-Environment Interaction in Melanoma - Ninth World Congress of Skin Cancer, Seville, Spain (Plenary Session). 2003.

26. Molecular Epidemiology of Melanoma – Plenary Session, First Melanoma Research Congress, Philadelphia, PA. June 24, 2003.

27.Keynote Speech: The Current Epidemiology of Melanoma. International Pigment Cell Research Society, Cape Cod, MA. September 5, 2003.

28.Melanoma: A Model for Gene-Environment Interaction – Plenary Session, ASPO, Bethesda, MD. March 16, 2004.

29. Primary Prevention: Do Sunscreens Work? First International Symposium on Melanoma and Other Cutaneous Malignancies, New York, NY. April 5, 2004.

30.The Role of Polymorphisms in DNA Repair in Melanoma: An International Study. International Society for Photobiology, Seoul, Korea. June 2004.

31. Gene-Gene Interaction in Melanoma, the Role of DNA Repair and MC1R. American Society for Photobiology, Seattle, WA, July 14, 2004.

32.Functional Assays for DNA Repair. Environmental Mutagen Society, Pittsburgh, PA..2004.

32

33. Association Studies in Molecular Epidemiology. Environmental Mutagenesis Society, San Francisco, CA, September 2005

34.How Could Sun Exposure Prevent Melanoma? 6th World Congress of Melanoma, Vancouver, CANADA, September 2005.

35.Gene-environment interaction in melanoma. Keystone Meeting, Santa Fe, NM, January 2006.

36.Vitamin D and Skin Cancer, AACR, Bethesda, April 2006.

37.2006. UV Light as a Protective Factor in Melanoma. ASCO Educational Session on Melanoma, Atlanta, GA, June 2006

38. 2006. The Strength of the Evidence for Vitamin D and Internal Malignancies. American Society for Photobiology, Puerto Rico, July 10, 2006

39. 2008. Clinical Oncologists Society of Australia. Gene-Environment Interaction and Melanoma, Sydney, Australia, November 19, 2008.

40. 2008. International Association of Cancer Registrars. Population-based studies using tumour banks, Sydney, Australia, November 20, 2008.

41.2010. 4th John R. Murren Conference. Risk Factors, Epidemiology, Screening and Diagnosis of Melanoma. Las Vegas, Nevada, March 26, 2010.

42. 2010. AACR 101st Annual Meeting. UV Exposure Patterns and Molecular and Clinical Phenotypes in an International Melanoma Study. Washington, DC, April 20, 2010.

43.2010. SMR 7th Annual Meeting. Gene-environment interaction in melanoma. Sydney, Australia, November 4, 2010.

44.2011. ASPO Meeting, Las Vegas, NV. Sun Exposure and Melanoma: A Double-Edged Sword. March 5, 2011.

45.2011. SWOG Harry Hines Symposium, San Antonio, TX. Sun Exposure and Melanoma: A Double Edged Sword. October 16, 2011.

46.2011. SMR 8th Annual Meeting. Tampa, FL. The Sun or UV: What is the Answer? November 11, 2011.

Current Grant and Contract Funding:

1. 1K05 CA131675-01A2 Melanoma Prevention-Using the SunPrincipal Investigator: Marianne BerwickPercent effort: 50%

33

Funding Organization: NIH/NCIDates: July 5, 2011 – June 30, 2016

2. P30 CA1181000 University of New Mexico Cancer Center Support GrantPrincipal Investigator: Cheryl WillmanPercent effort: 10%Funding Organization: NIH/NCIDates: September 1, 2005 – August 31, 2014

3. R01 CA 112243 - Melanoma RAS/BRAF MutationsPrincipal Investigator: Nancy ThomasFunding Organization: NIH/NCIPercent Effort: 10%Dates: 5/1/05-3/31/15

4. Sputum Adiponectin, Epigenetics and Asthma in WomenPrincipal Investigator: Akshay SoodFunding Organization: 2010 American Thoracic Society/Merck Translation Research Grant in AsthmaRole: Collaborator

5. R01 CA074592-09 Risk Factors for Nevus Development in ChildrenPrincipal Investigator: Lori CraneFunding Organization: NIH/NCIPercent Effort: 5%Dates: 4/01/10-6/30/15

6. R01 AR049342 The Framingham School Study of Nevi in Children: SONIC IIPrincipal Investigator: Allan HalpernFunding Organization: NIH/NIAIDPercent Effort: 5%Dates: 4/01/09 – 5/31/14

7. SBIR Phase II Solar Cell – Phase II Principal Investigator: BullerFunding Organization: NIH/NCIPercent Effort: 10%Dates: 10/1/2011-9/30/2013

Past Grant and Contract Funding

1. R01 CA 112524 - Sun Exposure and Mortality from Melanoma Principal Investigator: Marianne BerwickPercent effort: 10%Funding Organization: NIH/NCIDates: April 5, 2005 – March 31, 2012, NCE

34

2. ACS-170068 Assessment of differential capacity to repair DNA damage caused by alkylating agentsPrincipal Investigator: Bridget McCarthyFunding Organization: Illinois ACSPercent Effort: 2%Dates: 3/1/10-2/28/121.R21 ESO16637-01A1 Air Pollution, Systemic Inflammation and

3. Subclinical Atherosclerosis in High Altitude ChildrenPrincipal Investigator: Rodrigo ArmijosFunding Organization: NIH/NIEHSPercent Effort: 5%Dates: 9/19/09-7/31/11

4. R01 CA 112524 – ARRA SupplementPrincipal Investigator: Marianne BerwickFunding Organization: NIH/NCIPercent Effort: 0%Dates: 9/30/09-8/31/11

5.R01 CA 106807 – Indoor Tanning Use, DNA Repair and Risk of MelanomaPrincipal Investigator: DeAnn LazovichPercent Effort: 3%Funding Organization: NIH/NCIDates: 9/30/04-6/30/10 NCE

6. R24 HS016510-01 Expansion of Rural Health Care Research Infrastructure Through the ECHO ModelPercent Effort: 6.5%NIH/AHRQ (PI Arora)Dates: 9/1/07-8/31/10

7. R21 CA125397 Sequencing of Chr. 6 in MelanomaPrincipal Investigator: Jeremy EdwardsNIH/NCIPercent Effort: 5% 7/01/08-6/30/10

8. S11 ES013339 UTEP-UNM HSC Arch Program on Border AsthmaPrincipal Investigator: Nicholas PingitorePercent effort: 5%Funding Organization: NIH/NIEHSDates: September 1, 2005 – July 31, 2010

9. R01 CA 112243 - Melanoma RAS/BRAF MutationsPrincipal Investigator: Nancy ThomasFunding Organization: NIH/NCIPercent Effort: 4%

35

Dates: 5/1/05-3/31/10

10. Centers for Research to Reduce Oral Health DisparitiesPrincipal Investigator: Ralph Katz (New York University Dental School)Percent effort: 4.9%Funding Organization: NIH/NDIStarting and Stopping Dates: September 1, 2001 – August 31, 2008

11. The Framingham School Nevus StudyPrincipal Investigator: Allan Halpern (Memorial Sloan-Kettering Cancer Center)Percent Effort: 10%Dates: September 1, 2003 – August 31, 2008

12. Cancer Genetics Network Principal Investigator: Marianne BerwickFunding Organization: National Cancer InstitutePercent Effort: 5%Dates: 8/1/00 – 1/31/06

13. A Model for Genetic Susceptibility: MelanomaPrincipal Investigator: Marianne BerwickPercent effort: 20%Funding Agency: NIH/NCIDates: October 29, 1999 – December 31, 2005Amount awarded: $6,253,227

14. The Risk of Developing Cancer Among Fanconi Anemia HeterozygotesPrincipal investigator: Marianne Berwick Percent effort: 20 % Funding Organization: NIH/NCI Dates: April 1, 2001 – December 31, 2005Amount awarded: $ 1,092,074

15.Melanoma: Paths to ProgressionPrincipal Investigator: Marianne Berwick and Chris SanderFunding Organization: The Hazen FundDates: January 2003 – December 2004Amount Awarded: $300,000

16.Genetic Susceptibility to Soft Tissue SarcomaPrincipal investigator: Marianne BerwickPercent effort: in kindFunding Organization: Kristin Ann Carr Fund, Memorial Sloan-Kettering Cancer Center Dates: January 1997 – December 2003Amount Awarded: $600,000

17. Estrogen, Diet, Genetics and Endometrial CancerPrincipal Investigator: Sara Olson

36

Percent effort: 5%Funding Organization: NIH/NCIDates: July 1, 2001 – December 2003Amount Awarded: $2,500,000 (approximately)

18. A Randomized Trial of Skin Self-ExaminationPrincipal Investigator: Martin Weinstock (Brown University)Percent effort: 5%Funding Organization: NIH/NCIDates: February 1, 1999 – December 31, 2003Amount Awarded: $1,500,000 (approximately)

19. New Mexico NIEHS CenterPrincipal Investigator: Scott BurchielPercent effort: 10%Funding Organization: NIH/NIEHSDates: April 1, 2006 – March 31, 2007

20. Pilot Study: Gene-Environment Interaction in MelanomaPrincipal Investigator: Marianne BerwickPercent effort: in kindFunding Organization: The Byrne Fund; the Schultz FoundationDates: January 1, 1997 – December 31, 2000Amount Awarded: $225,000

21. Interdisciplinary Studies in Cancer EpidemiologyPrincipal Investigator: Ernst Wynder (The American Health Foundation)Percent Effort: 10%Funding Organization: NIH/NCIDates: January 1995 – December 1997Amount Awarded: $120,000 (approximately) (subcontract)

22. Statistical Methods in Cancer Prevention StudiesPrincipal Investigator: Colin BeggPercent Effort: 10%Funding Organization: NIH/NCIDates: January 1995 – December 1999Amount Awarded: $20,000 (Berwick portion – approximate)

23. K07 CA 01695 DNA Repair Measures as Biomarkers for Cancer PreventionPrincipal Investigator: Marianne BerwickPercent Effort: 80%Funding Organization: NIH/NCI Dates: September 1994 – August 1999Amount Awarded: $668,750

24. UVB and MelanomaPrincipal Investigator: Patricia Buffler (UC Berkeley)Percent Effort: In kind

37

Funding Organization: NIH/NCHDates: September 1993-August 1995Amount Awarded: $100,000 plus IDC

25. Vitamin E and DNA Repair in Lymphocytes and MonocytesPrincipal Investigator: Marianne BerwickPercent Effort: Overlap with (#7)Funding Organization: NIH/NCI 1R03CA058581-01A1Dates: September 1994 – August 1996Amount Awarded: $162,500

26. A Feasibility Study to Assess the Change in Extent of Disease in Melanoma Over TimePrincipal Investigator: Marianne BerwickFunding Organization: NIH/NCIDates: September 1990 – August 1991Amount Awarded: $90,000

27. Evaluation of Skin Self-Examination Protocol Among Groups at High Risk for MelanomaPrincipal Investigator: Marianne BerwickFunding Organization: Yale University: Hull Award and CCRU Developmental FundsDates: January 1988 – December 1991Amount Awarded: $50,000

28. Nasopharyngeal Cancer and Formaldehyde ExposurePrincipal Investigator: Tom Vaughan (University of Washington)Funding Organization: NIH/NCIDates: January 1988 – December 1994Amount Awarded: $100,000 (approximately)

29. Case-Control Study of Skin Exam and Lethal MelanomaPrincipal Investigator: Dwight Janerich (Program Project PI)Marianne Berwick (Project PI)Funding Organization: NIH/NCIDates: September 1986 – June 1992Amount Awarded: $2,000,000 (approximately)

30. An Intervention to Educate Parents of Newborns to Avoid Excess Sun ExposurePrincipal Investigator: Marianne BerwickFunding Organization: Biomedical Research Support Grant (BRSG) and Yale-New Haven Hospital AuxiliaryDates: September 1988 – August 1989Amount Awarded: $75,000

31. Epidemiologic Study of Health Effects Associated with Exposure to Unvented Kerosene Heaters

38

Principal Investigator: Jan StolwijkFunding Organization: Consumer Product Safety CommissionDates: January 1982 – December 1986Amount Awarded: $200,000 (approximately)

Teaching / Education

Post Doctoral Students

Salina Torres, Ph.D., January 2, 2009 – present. NCI-Postdoctoral fellowship, ASERT Fellow. Gender differences in survival from melanoma.

Esther Erdei, Ph.D., January 1, 2004 – December 31, 2007. Immunology of melanoma. Now a Staff Scientist at UNM.

Ph.D. student mentoring. Jenna Lilyquist, September 2010 – to present. University of New

Mexico BSGP Program.

Kirsten White, September 2011 – to present. University of New Mexico BSGP Program.

Lisa Paddock, June 2005 (Rutgers University), Ten Year Follow-up of Screening for Melanoma.

Somdat Mahabir, June 2001 (New York University), The Effects of Vitamin E on DNA Damage in Cancer Patients

Ya-ting Chen, June 1993 (Yale University), Malignant melanoma risk factors by anatomic site: a case-control study and polychotomous logistic regression analysis.

Medical Student mentoring

Bernice Glover, June 1991 (Yale University), MD/MPH, A Validation Study of Benign Skin Biopsies

Maureen Smith, June 1992 (Yale University), MD/MPH, Hormonal and Reproductive Factors Influencing Risk of Melanoma in Women

Nina Fisher, June 1997 (Yale University School of Medicine), MD Thesis, A Comparison of Patients with Familial and Sporadic Cutaneous Melanoma

Sepidah Bagheri, June 1993 (Yale University School of Medicine), MD Thesis, An Intervention to Increase Skin Self-Examination

39

Justin Taylor, Summer 2004 (University of New Mexico School of Medicine). Minority student project, Polymorphisms in Pre-neoplastic Oral Cancer.

Tim Wilcox and Julie Young, 2005-7 (University of New Mexico), Distance traveled and Melanoma Diagnosis

David Kunkel, 2006 (University of New Mexico). The divergent pathway hypothesis and melanoma.

Anne Lachiewicz, 2006 (University of North Carolina). Melanoma characteristics.

Justin Taylor, 2007-2009 (University of New Mexico), Genetics, Ethnic Differences and CML

Willie Nunez and Joshu Raeten, 2006-2008 (University of New Mexico), Smokeless Tobacco Use Among High School Students in Roswell, NM

Kathleen Lopez and Michael Reyes, 2007-2009 (University of New Mexico), Number of Nevi and Survival with Melanoma

Amy Nixon and Kathleen Willard, 2008-2010 (University of New Mexico), Sunbed Usage between 1980 and 2000 in the Northeastern United States.

Desi and Veneta Ianakieva, 2010-2012 (University of New Mexico), Patterns of mortality by gender in Connecticut and in GEM.

Masters student mentoring.

Meg Fulton, June 1986 (Yale University), Project Alert: Phase I, “No Butts About It”, Tobacco Prevention Program for Youth

Elizabeth Platz, June 1987 (Yale University), A Case-Control Study of Melanoma and Industry in Connecticut

Suzanne Lea, June 1989 (Yale University), UVB and Melanoma Risk in Connecticut

Ya-Ting Chen, June 1988 (Yale University), Suntan Lamps and Risk for Melanoma.

Su-ting Luo, June 1989 (Yale University), Survival Analysis of Cutaneous Melanoma Cases in Connecticut, 1973-1984.

Sybil Eng, June 1996 (Columbia University), Genetic Risk for the Development of Melanoma

40

Barbara Rothenberg, June 1998 (University of Michigan), UV Risk Factors for the Development of Melanoma

Sae-hee Kim, June 2002 (Yale University), Genetic Risk Factors for the Development of Soft Tissue Sarcoma

Fredine Lauer, June 2010 (University of New Mexico), DNA repair single nucleotide polymorphisms and melanoma

Undergraduate minority student mentoring

Quinton Smith, academic years 2007-present. (Undergraduate program – minority programs (STEP-UP, Johns Hopkins summer training, NIH summer programs) – Vitamin D and UV Exposure.

Jaclyn Herrera – IMSD student – 2008 – Mutagen sensitivity and melanoma.

Cynthia Baca – IMSD student – 2006 – Breast cancer and cytokines.

Amanda Mackey – summer 2005 (UNM summer school minority student project) – P450 polymorphisms and oral cancer in Puerto Rico.

High school students (INTEL Fellowships)

Diana Lewis, 1998, Semi-finalist

Shivanna Naidoo, 1999, Semi-finalist

Alison Barz, 2000, Semi-finalist

Christina Shannon, 2006

Classroom, laboratory teaching, and tutoring

Director, Epidemiology Level I – Master of Science in Clinical Research – Fall 2009, Fall 2010

Director, Epidemiology and Biostatistics – Phase I – University of New Mexico School of Medicine - 2005

Guest lectures – Spring 2005; BMS516: Molecular Genetics and Genomics, Pharm 594: Application of Genomics and Proteomics to Toxicology

41

2002, Spring 1 week course, IARC (International Agency for Research on Cancer), Directed Course on Molecular Epidemiology, New York City, 35 students (1 lecture also)

2001, Fall 1 week course, NIVA (Nordiska Institutionen for Vidareutbildning), 2 Lectures, Tallin, Estonia

1999-2003, week-long courses on Molecular Epidemiology, IARC, Lyon France, Turin, Italy, and Singapore, Lectures on DNA Repair in Epidemiology

1991-2003, Guest lecturer, Yale University School of Medicine, Department of Epidemiology and Public Health (Cancer Epidemiology, Methods in Epidemiology, Molecular Epidemiology)

1994-2002, 9 week course in Chronic Disease Epidemiology (1 lecture and twice a week discussion group), Cornell Medical School, New York

1988-1991, Lecturer, Seminar in Biostatistics and Chronic Disease Epidemiology, Yale University School of Medicine, Department of Epidemiology and Public Health

1986, Teaching Assistant, Introduction to Statistics and Data Management, Yale University School of Medicine, Department of Epidemiology and Public Health

1985-86, Acting Instructor, Environmental Epidemiology, Yale University School of Medicine, Department of Epidemiology and Public Health

(1964-1969, 1971-1973 Secondary School Teacher of English: Oakland, CA; Missoula, MT; Branford, CT; Bryan, TX)

Continuing Medical Education

Primary Prevention: Do Sunscreens Work? First International Symposium on Melanoma and Other Cutaneous Malignancies, New York, NY.

2002, ASCO Symposium, Molecular Epidemiology: Sorting out Low-Penetrance Genes, Boston, MA

1997. Familial Melanoma. Cancer Genetic Counseling and Testing: A Multidisciplinary Course. Co-sponsored by Memorial Sloan-Kettering Cancer Center and The Sarah Lawrence College Human Genetics Program. New York, NY.

42

1997. The Epidemiology of Melanoma. Cutaneous Melanoma 1997 Symposium. CME sponsored by The Skin Cancer Foundation and Memorial Sloan-Kettering Cancer Center, New York, NY.

Mentoring of faculty in education

Conduct Symposium on Scientific Writing, American Society for Preventive Oncology, March 2003, Philadelphia, PA

Mentor for Chuck Wiggins. Weekly 2004 - 2009. Four papers developed, grant application in process.

Mentor for Melissa Gonzales. Weekly 2004 (to date). K0-1 Award

Mentor for David Polsky, MD, PhD, New York University, K0-8 funded, 1998-2003. We have worked together on grant applications and have published one paper together.

Mentor for Susan Oliveria, ScD, Memorial Sloan-Kettering Cancer Center, K0-7 funded, 2001-2006.

Mentor for Jennifer Hay, Ph.D., Memorial Sloan-Kettering Cancer Center, K0-7 funded, 2003-2008.

Mentor for Kristina Flores. Weekly – K0-1 Mentor Funded

Mentor for Akshay Sood. Weekly – K23 Mentor Funded

Mentor for Patti Kapsner – GCRC Scholar – 2005-2006

Service

 University, SOM, HSC administrative duties

January 1, 2004 – present. Chief, Division of Epidemiology, Department of Internal Medicine, UNM

January 1, 2004 – present. Co-leader of Program in Epidemiology and Cancer Prevention, Cancer Research and Treatment Center, UNM

January 2, 2004 – present. Associate Director for Population Science, Cancer Research and Treatment Center, UNM.

April 2004 – 2005. Member of the University of New Mexico Faculty Senate.

2006 – Alternate member for the Senate Graduate Committee.

43

University, SOM, HSC, department committees

UNM Cancer Center – 2011 – present. Head of Search committee for Population Science Surface recruits.

CTSC – 2006. Member of the Education Committee

CTSC – 2006, Member of the Translational Science Committee.

November 2004 – present. GCRC Scholars Committee

2005-6. Head of Search Committee for Cancer Epidemiologist, Division of Epidemiology, Department of Internal Medicine

January 2004 – 2005. Head of Search Committee for Environmental Epidemiologist, Division of Epidemiology, Department of Internal Medicine.

January 2004 – August 2004. Head of Search Committee for Cancer Epidemiologist (hired Deirdre Hill). Division of Epidemiology, Department of Internal Medicine.

January 2004 – 2009. Head of Search Committee for Director for Cancer Prevention. Division of Epidemiology, Department of Internal Medicine.

January 2004 – August 2004. Member of Search Committee for Biostatistics. Division of Epidemiology, Department of Internal Medicine.

April 2004. Member of Search Committee for Chair of Cardiology, Department of Internal Medicine

May 2004. Member of Search Committee for Faculty in Pharmacogenomics.

2009-2010. Member of Search Committee for Dean of Research in the Department of Pediatrics.

 Local, state, regional, national and international committees

June 2004 to present. Member, Steering Committee. Melanoma Research Foundation.

September 2000 -2001. External Advisory Committee for the European Union grant GEN-AIR.

2005-6. New Mexico Cancer Council.

44

2006-2015. Scientific Councilor for the Radiation Effects Research Foundation in Hiroshima, Japan – National Academy of Sciences.

2010 to present. Member of the PDQ Cancer Genetics Editorial Advisory Board

45